Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2000The Journal of ImmunologyOpen Access

Cutting Edge: The Tumor Counterattack Hypothesis Revisited: Colon Cancer Cells Do Not Induce T Cell Apoptosis Via the Fas (CD95, APO-1) Pathway

View Full Paper
Ask AI
Bookmark
Share

Authors

NFNathalie Favre-FélixAFAnnie FromentinAHArlette Hammann

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Favre-Félix et al. (2000) studied this question.

synapsesocial.com/papers/6a9188112e07877a42ab4eaahttps://doi.org/10.4049/jimmunol.164.10.5023
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Local Fas/APO‐1 (CD95) ligand‐mediated tumor cell killing <i>in vivo</i>1995 · 197 citations
  2. 2Conversion of Membrane-bound Fas(CD95) Ligand to Its Soluble Form Is Associated with Downregulation of Its Proapoptotic Activity and Loss of Liver Toxicity1998 · 813 citations
  3. 3Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes.1998 · 239 citations
  4. 4The Fas Death Factor1995 · 4,022 citations